What if you'd held KPRX?
A $1,000 investment in Kiora Pharmaceuticals, Inc. (KPRX) at the month-end close of 2015-02 would be worth $0.08 at the close of 2026-08 — -100.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,663.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $595 | -40.5% |
| 2017 | $391 | -34.4% |
| 2018 | $170 | -56.5% |
| 2019 | $244 | +43.7% |
| 2020 | $120 | -50.8% |
| 2021 | $36.74 | -69.4% |
| 2022 | $2.09 | -94.3% |
| 2023 | $0.32 | -84.8% |
| 2024 | $0.22 | -29.8% |
| 2025 | $0.13 | -40.3% |
| 2026 | $0.18 | +32.0% |
Best and worst month-end to buy
The best single month-end close to have bought KPRX was 2026-03 ($1.93): $1,000 then is $1,347 today. The worst was 2015-07 ($38,610): $1,000 then is $0.07.
FAQ
What would $1,000 in KPRX be worth today?
A $1,000 investment in Kiora Pharmaceuticals, Inc. (KPRX) at the start of 2015 would be worth about $0.08 today, a total return of -100.0%. Dividends are reinvested in these figures.
What were the best and worst years for KPRX?
Kiora Pharmaceuticals, Inc. (KPRX)'s strongest calendar year since 2015 was 2019, a +43.7% return — $1,000 held through that year became about $1,437 by year-end. Its weakest year was 2022, at -94.3%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in KPRX have grown?
Investing $100 at the end of every month since 2015-02 would have grown to about $3,227 on $13,900 invested.
Did KPRX beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,663. KPRX trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Kiora Pharmaceuticals, Inc. (KPRX) historical total-return data from 2015-02 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.